Among all 79 patients, 65 of whom were included in our earlier study (Ma et al, 2002), there were nine responders (41%) in 22 patients with tumours with low MGMT expression, while there were 11 responders (19%) in 57 patients carrying tumours with high expression of MGMT. Here, MGMT is linked to neoplasm.